Hussein A A, et al. studied several candidate compounds which they then optimized and analyzed to determine their structural similarity with the most similar approved drugs to accelerate the development of a potent anti-SARS-CoV-2 drug in their preclinical study to be recommended in design of a clinical study.
Hussein A A, alichuguza dawa kadhaa zilizoteuliwa, kisha akaboresha na kuchambua mfanano wao na mifupa na dawa za kiwango cha juu zilizoidhinishwa ili kuharakisha maendeleo ya dawa inayowezekana ya kuzuia SARS-CoV-2 na uchunguzi wake wa dawa kupendekezwa katika muundo wa uchunguzi wa kliniki.